The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (18.41) USD. With the latest stock price at 18.41 USD, the upside of Neogenomics Inc based on DCF is -200.0%.
Based on the latest price of 18.41 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 200.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.6% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (67.06) - (11.83) | (18.41) |
| Upside | -464.3% - -164.3% | -200.0% |